The impact of integrated omics technologies for patients with rare diseases

Bibliography

• Global Genes. RARE Facts and Statistics. Available from: www.globalgenes.org/rare-diseases-facts-statistics [Last accessed 2 October 2014]
   Google Scholar
• López-Bastida J, Oliva-Moreno J. Cost of illness and economic evaluation in rare diseases. Adv Exp Med Biol 2010;686:273-82
   Google Scholar
• Landfeldt E, Lindgren P, Bell CF, et al. The burden of Duchenne muscular dystrophy: an international, cross-sectional study. Neurology 2014;83(6):529-36
   PubMed Web of Science ®Google Scholar
• Danielsson K, Mun LJ, Lordemann A, et al. Next-generation sequencing applied to rare diseases genomics. Expert Rev Mol Diagn 2014;14(4):469-87
   Web of Science ®Google Scholar
• Gut IG. New sequencing technologies. Clin Transl Oncol 2013;15(11):879-81
   Google Scholar
• Rodwell C, Aymé S. editors. 2014 Report on the state of the art of rare diseases activities in Europe – Part I: overview of rare disease activities in Europe. Available from: http://www.eucerd.eu/upload/file/Reports/2014ReportStateofArtRDActivities.pdf [Last accessed 18 October 2014]
   Google Scholar
• Lander ES, Linton LM, Birren B, et al. Human genome. Nature 2001;409:860-921
   PubMed Web of Science ®Google Scholar
• Hayden EC. Technology: the $1,000 genome. Nature 2014;507:294-5
   PubMed Web of Science ®Google Scholar
• Mardis ER. A decade’s perspective on DNA sequencing technology. Nature 2011;470(7333):198-203
   PubMed Web of Science ®Google Scholar
• van Dijk EL, Auger H, Jaszczyszyn Y, Thermes C. Ten years of next-generation sequencing technology. Trends Genet 2014;30(9):418-26
   PubMed Web of Science ®Google Scholar
• Boycott KM, Dyment DA, Sawyer SL, et al. Identification of genes for childhood heritable diseases. Annu Rev Med 2014;65:19-31
   PubMed Web of Science ®Google Scholar
• Goldstein DB, Allen A, Keebler J, et al. Sequencing studies in human genetics: design and interpretation. Nat Rev Genet 2013;14:460-70
   PubMed Web of Science ®Google Scholar
• MacArthur DG, Manolio TA, Dimmock DP, et al. Guidelines for investigating causality of sequence variants in human disease. Nature 2014;24:469-76
   Google Scholar
• Brownstein CA, Beggs AH, Homer N, et al. An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge. Genome Biol 2014;15(3):R53
   PubMed Web of Science ®Google Scholar
• Knoppers BM, Harris JR, Budin-Ljøsne I, Dove ES. A human rights approach to an international code of conduct for genomic and clinical data sharing. Hum Genet 2014;133(7):895-903
   PubMed Web of Science ®Google Scholar
• Lappalainen T, Sammeth M, Friedländer MR, et al. Transcriptome and genome sequencing uncovers functional variation in humans. Nature 2013;501(7468):506-11
   PubMed Web of Science ®Google Scholar
• Zhao Y, Jensen ON. Modification-specific proteomics: strategies for characterization of post-translational modifications using enrichment techniques. Proteomics 2009;9(20):4632-41
   PubMed Web of Science ®Google Scholar
• Wilhelm M, Schlegl J, Hahne H, et al. Mass-spectrometry-based draft of the human proteome. Nature 2014;509(7502):582
   PubMed Web of Science ®Google Scholar
• Kim MS, Pinto SM, Getnet D, et al. A draft map of the human proteome. Nature 2014;509(7502):575-81
   PubMed Web of Science ®Google Scholar
• Rodríguez-Suárez E, Siwy J, Zürbig P, Mischak H. Urine as a source for clinical proteome analysis: from discovery to clinical application. Biochim Biophys Acta 2014;1844:884-98
   PubMed Web of Science ®Google Scholar
• Ayoglu B, Chaouch A, Lochmüller H, et al. Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophies. EMBO Mol Med 2014;6:918-36
   PubMed Web of Science ®Google Scholar
• Nadarajah VD, van Putten M, Chaouch A, et al. Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD). Neuromuscul Disord 2011;21:569-78
   PubMed Web of Science ®Google Scholar
• Dumas ME. Metabolome 2.0: quantitative genetics and network biology of metabolic phenotypes. Mol Biosyst 2012;8(10):2494-502
   PubMedGoogle Scholar
• Xu EY, Schaefer WH, Xu Q. Metabolomics in pharmaceutical research and development: metabolites, mechanisms and pathways. Curr Opin Drug Discov Devel 2009;12(1):40-52
   PubMedGoogle Scholar
• Dharuri H, Demirkan A, van Klinken JB, et al. Genetics of the human metabolome, what is next? Biochim Biophys Acta 2014;1842(10):1923-31
   Google Scholar
• Devuyst O, Knoers NV, Remuzzi G, et al. Rare inherited kidney diseases: challenges, opportunities, and perspectives. Lancet 2014;383(9931):1844-59
   PubMed Web of Science ®Google Scholar
• Horvath R, Kemp JP, Tuppen HA, et al. Molecular basis of infantile reversible cytochrome c oxidase deficiency myopathy. Brain 2009;132(Pt 11):3165-74
   Google Scholar
• Banugaria SG, Prater SN, Patel TT, et al. Algorithm for the early diagnosis and treatment of patients with cross reactive immunologic material-negative classic infantile pompe disease: a step towards improving the efficacy of ERT. PLoS One 2013;8(6):67052
   Web of Science ®Google Scholar
• Schwab M, Schaeffeler E. Pharmacogenomics: a key component of personalized therapy. Genome Med 2012;4(11):93
   PubMedGoogle Scholar
• Bushby K, Finkel R, Wong B, et al. Ataluren treatment of patients with nonsense mutation dystrophinopathy. Muscle Nerve 2014;50(4):477-87
   PubMed Web of Science ®Google Scholar
• Broad Institute. Creating a global alliance to enable responsible sharing of genomic and clinical data. Available from: http://www.broadinstitute.org/files/news/pdfs/GAWhitePaperJune3.pdf [Last accessed 18 October 2014]
   Google Scholar
• Knoppers BM. International ethics harmonization and the global alliance for genomics and health. Genome Med 2014;6(2):13
   PubMedGoogle Scholar
• Global Alliance for Genomics and Health. Available from: www.genomicsandhealth.org [Last accessed 2 October 2014]
   Google Scholar
• Montserrat Moliner A, Waligóra J. The European union policy in the field of rare diseases. Public Health Genomics 2013;16:268-77
   PubMed Web of Science ®Google Scholar
• The International Rare Disease Research Consortium (IRDiRC). Available from: www.irdirc.org [Last accessed 2 October 2014]
   Google Scholar
• International Rare Disease Research Consortium (IRDiRC) Policies and Guidelines. Available from: www.irdirc.org/wp-content/uploads/2013/06/IRDiRC_Policies_Longversion_24May2013.pdf [Last accessed 2 October 2014]
   Google Scholar
• RD-Connect. Available from: www.rd-connect.eu [Last accessed 2 October 2014]
   Google Scholar
• EURenOmics. Available from: www.eurenomics.eu [Last accessed 2 October 2014]
   Google Scholar
• NeurOmics. Available from: www.rd-neuromics.eu [Last accessed 2 October 2014]
   Google Scholar
• Thompson R, Johnston L, Taruscio D, et al. RD-Connect: an integrated platform connecting databases, registries, biobanks and clinical bioinformatics for rare disease research. J Gen Intern Med 2014;29(Suppl 3):780-7
   Google Scholar
• Mascalzoni D, Dove ES, Rubinstein Y, et al. International Charter of principles for sharing bio-specimens and data 2014. Eur J Hum Genet 2014. [ Epub ahead of print]
   Google Scholar
• NeurOmics publications. Available from: http://rd-neuromics.eu/publications [Last accessed 2 October 2014]
   Google Scholar
• Kishnani PS, Amartino HM, Lindberg C, et al. Timing of diagnosis of patients with Pompe disease: data from the Pompe registry. Am J Med Genet A 2013;161A(10):2431-43
   Google Scholar
• Bladen CL, Rafferty K, Straub V, et al. The TREAT-NMD Duchenne muscular dystrophy registries: conception, design, and utilization by industry and academia. Hum Mutat 2013;34(11):1449-57
   PubMed Web of Science ®Google Scholar
• Bladen CL, Thompson R, Jackson JM, et al. Mapping the differences in care for 5,000 spinal muscular atrophy patients, a survey of 24 national registries in North America, Australasia and Europe. J Neurol 2014;261(1):152-63
   Google Scholar
• Development of the European Platform on Rare Diseases Registration. Available from: www.rare-diseases.eu/wp-content/uploads/2014/05/0202_Ciaran_NICHOLL.pdf [Last accessed 2 October 2014]
   Google Scholar
• EuroBioBank. Available from: www.eurobiobank.org [Last accessed 2 October 2014]
   Google Scholar
• Mora M, Angelini C, Bignami F, et al. The EuroBioBank Network: ten years of hands-on experience of collaborative, transnational biobanking for rare diseases. Eur J Hum Genet 2014; In press
   Google Scholar
• Swaminathan GJ, Bragin E, Chatzimichali EA, et al. DECIPHER: web-based, community resource for clinical interpretation of rare variants in developmental disorders. Hum Mol Genet 2012;21(R1):R37-44
   Google Scholar
• BBMRI: biobanking and BioMolecular resources Research Infrastructure. Available from: www.bbmri.eu [Last accessed 2 October 2014]
   Google Scholar
• Lochmüller H, Aymé S, Pampinella F, et al. The role of biobanking in rare diseases: european consensus expert group report. Biopreserv Biobank 2009;7(3):155-6
   PubMedGoogle Scholar
• Harris JR, Burton P, Knoppers BM, et al. Toward a roadmap in global biobanking for health. Eur J Hum Genet 2012;20(11):1105-11
   PubMed Web of Science ®Google Scholar
• ELIXIR. Available from: www.elixir-europe.org [Last accessed 2 October 2014]
   Google Scholar
• Crosswell LC, Thornton JM. ELIXIR: a distributed infrastructure for European biological data. Trends Biotechnol 2012;30(5):241-2
   PubMed Web of Science ®Google Scholar
• The European Genome phenome Archive. Available from: www.ebi.ac.uk/ega [Last accessed 2 October 2014]
   Google Scholar
• UniProt. Available from: www.uniprot.org [Last accessed 2 October 2014]
   Google Scholar
• Groft SC. Rare diseases research: expanding collaborative translational research opportunities. Chest 2013;144(1):16-23
   PubMedGoogle Scholar
• Celli J, Dalgleish R, Vihinen M, et al. Curating gene variant databases (LSDBs): toward a universal standard. Hum Mutat 2012;33(2):291-7
   Google Scholar
• Landrum MJ, Lee JM, Riley GR, et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res 2014;42(Database issue):D980-5
   PubMed Web of Science ®Google Scholar
• Fernández-Suárez XM, Rigden DJ, Galperin MY. The 2014 nucleic acids research database issue and an updated NAR online molecular biology database collection. Nucleic Acids Res 2014;42(Database issue):D1-6
   Google Scholar
• Köhler S, Doelken SC, Mungall CJ, et al. The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Res 2014;42(Database issue):D966-74
   PubMed Web of Science ®Google Scholar
• Girdea M, Dumitriu S, Fiume M, et al. PhenoTips: patient phenotyping software for clinical and research use. Hum Mutat 2013;34(8):1057-65
   PubMed Web of Science ®Google Scholar